Establishment and characterization of a novel cell line derived from human thymoma AB tumor

Laboratory Investigation

Volumn 92, Issue 11, 2012, Pages 1564-1573

  Gökmen Polar, Yesim ^a   Sanders, Kerry L ^a   Goswami, Chirayu P ^a   Cano, Oscar D ^a   Zaheer, Narjis A ^a   Jain, Rohit K ^a   Kesler, Kenneth A ^a   Nelson, Robert P ^a   Vance, Gail H ^a   Smith, Danielle ^a   Li, Lang ^a   Cardoso, Angelo A ^a   Badve, Sunil ^a   Loehrer, Patrick J ^a   Sledge, George W ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

gene expression analysis; human epithelial cancer cell lines; thymoma

Indexed keywords

BETA1 INTEGRIN; CD24 ANTIGEN; CD9 ANTIGEN; EPITHELIAL CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; PROTEIN P63; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1;

ADULT; ARTICLE; CANCER STAGING; CASE REPORT; CHROMOSOME ANALYSIS; CONTROLLED STUDY; EPITHELIUM; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYMOMA; TUMOR CELL LINE; TUMOR XENOGRAFT;

EID: 84868568119     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2012.115     Document Type: Article

References (41)

1. Rosai J, Sobin LH. Histological typing of tumors. In: World Health Organization International Histological Classification of Tumours, Heidelberg, 1999.
2. Travis WD. World Health Organization, International Agency for Research on Cancer, International Association for the Study of Lung Cancer, International Academy of Pathology. Pathology and genetics of tumours of the lung, pleura, thymus and heart; Lyon, Oxford: IARC Press. Oxford University Press (distributor), 2004, p 344.
3. Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981; 48:2485-2492. (Pubitemid 12228012)
4. Casey EM, Kiel PJ, Loehrer Sr PJ. Clinical management of thymoma patients. Hematol Oncol Clin North Am 2008;22:457-473. (Pubitemid 351726412)
5. Jain RK, Mehta RJ, Henley JD, et al. WHO types A and AB thymomas: not always benign. Mod Pathol 2010;23:1641-1649.
6. Vladislav T, Jain RK, Alvarez R, et al. Extrathoracic metastases of thymic origin: a review of 35 cases. Mod Pathol 2012;25:370-377.
7. Loehrer Sr PJ, Jiroutek M, Aisner S, et al. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial. Cancer 2001;91:2010-2015. (Pubitemid 32476364)
8. Hanna N, Gharpure VS, Abonour R, et al. High-dose carboplatin with etoposide in patients with recurrent thymoma: the Indiana University experience. Bone Marrow Transplant 2001;28:435-438. (Pubitemid 33069621)
9. Okereke IC, Kesler KA, Morad MH, et al. Prognostic indicators after surgery for thymoma. Ann Thorac Surg 2010;89:1071-1077.
10. Girard N, Shen R, Guo T, et al. Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas. Clin Cancer Res 2009;15:6790-6799.
11. Giaccone G. Treatment of malignant thymoma. Curr Opin Oncol 2005;17:140-146. (Pubitemid 40516282)
12. Giaccone G, Rajan A, Ruijter R, et al. Imatinib mesylate in patients with WHO B3 thymomas and thymic carcinomas. J Thorac Oncol 2009;4:1270-1273.
13. Kuzume T, Kubonishi I, Takeuchi S, et al. Establishment and characterization of a thymic carcinoma cell line (Ty-82) carrying t(15;19) (q15;p13) chromosome abnormality. Int J Cancer 1992;50:259-264.
14. Ehemann V, Kern MA, Breinig M, et al. Establishment, characterization and drug sensitivity testing in primary cultures of human thymoma and thymic carcinoma. Int J Cancer 2008;122:2719-2725. (Pubitemid 351631373)
15. Inai K, Takagi K, Takimoto N, et al. Multiple inflammatory cytokineproductive ThyL-6 cell line established from a patient with thymic carcinoma. Cancer Sci 2008;99:1778-1784.
16. Langdon SP (ed). Cancer Cell Culture: Methods and Protocols: Springer Protocols, 2003.
17. Badve S, Goswami C, Gökmen-Polar Y, et al. Molecular analysis of thymoma. PLoS ONE 2012;7:e42669.
18. Patel DD, Whichard LP, Radcliff G, et al. Characterization of human thymic epithelial cell surface antigens: phenotypic similarity of thymic epithelial cells to epidermal keratinocytes. J Clin Immunol 1995; 15:80-92.
19. Webster JA, Beck AH, Sharma M, et al. Variations in stromal signatures in breast and colorectal cancer metastases. J Pathol 2010;222:158-165.
20. Rody A, Holtrich U, Pusztai L, et al. T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers. Breast Cancer Res 2009;11:R15.
21. Inoue M, Starostik P, Zettl A, et al. Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas. Cancer Res 2003;63:3708-3715. (Pubitemid 36793056)
22. Penzel R, Hoegel J, Schmitz W, et al. Clusters of chromosomal imbalances in thymic epithelial tumours are associated with the WHO classification and the staging system according to Masaoka. Int J Cancer 2003;105:494-498. (Pubitemid 36578553)
23. Lee GY, Yang WI, Jeung HC, et al. Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization. BMC Genomics 2007;8:305.
24. Zettl A, Strobel P, Wagner K, et al. Recurrent genetic aberrations in thymoma and thymic carcinoma. Am J Pathol 2000;157:257-266. (Pubitemid 30642585)
25. Strobel P, Marx A, Zettl A, et al. Thymoma and thymic carcinoma: an update of the WHO Classification 2004. Surg Today 2005;35: 805-811. (Pubitemid 41374382)
26. Neve RM, Chin K, Fridlyand J, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006;10:515-527. (Pubitemid 44854747)
27. Dotto J, Pelosi G, Rosai J. Expression of p63 in thymomas and normal thymus. Am J Surg Pathol 20071161-1167.
28. Berezowski K, Grimes MM, Gal A, et al. CD5 immunoreactivity of epithelial cells in thymic carcinoma and CASTLE using paraffinembedded tissue. Am J Clin Pathol 1996;106:483-486. (Pubitemid 26332998)
29. Hishima T, Fukayama M, Fujisawa M, et al. CD5 expression in thymic carcinoma. Am J Pathol 1994;145:268-275. (Pubitemid 24245825)
30. Kornstein MJ, Rosai J. CD5 labeling of thymic carcinomas and other nonlymphoid neoplasms. Am J Clin Pathol 1998;109:722-726. (Pubitemid 28247271)
31. Henley JD, Cummings OW, Loehrer Sr PJ. Tyrosine kinase receptor expression in thymomas. J Cancer Res Clin Oncol 2004;130: 222-224. (Pubitemid 38553631)
32. Henley JD, Koukoulis GK, Loehrer Sr PJ. Epidermal growth factor receptor expression in invasive thymoma. J Cancer Res Clin Oncol 2002;128:167-170.
33. Dal Cin P, De Wolf-Peeters C, Aly MS, et al. Ring chromosome 6 as the only change in a thymoma. Genes Chromosomes Cancer 1993;6: 243-244. (Pubitemid 23111761)
34. Goh SG, Lau LC, Sivaswaren C, et al. Pseudodicentric (16;12)(q11;p11.2) in a type AB (mixed) thymoma. Cancer Genet Cytogenet 2001;131: 42-47. (Pubitemid 33081157)
35. Cowell JK, LaDuca J, Rossi MR, et al. Molecular characterization of the t(3;9) associated with immortalization in the MCF10A cell line. Cancer Genet Cytogenet 2005;163:23-29. (Pubitemid 41597006)
36. Rizou H, Bardi G, Arnaourti M, et al. Metaphase and interphase cytogenetics in fibroadenomas of the breast. In Vivo 2004;18:703-711.
37. Muleris M, Zafrani B, Validire P, et al. Cytogenetic study of 30 colorectal adenomas. Cancer Genet Cytogenet 1994;74:104-108. (Pubitemid 24208876)
38. Willson JK, Bittner GN, Oberley TD, et al. Cell culture of human colon adenomas and carcinomas. Cancer Res 1987;47:2704-2713. (Pubitemid 17083162)
39. Paraskeva C, Finerty S, Mountford RA, et al. Specific cytogenetic abnormalities in two new human colorectal adenoma-derived epithelial cell lines. Cancer Res 1989;49:1282-1286. (Pubitemid 19074850)
40. Nakajima H, Nakajima HO, Soonpaa MH, et al. Heritable lymphoepithelial thymoma resulting from a transgene insertional mutation. Oncogene 2000;19:32-38. (Pubitemid 30066348)
41. Ross DT, Perou CM. A comparison of gene expression signatures from breast tumors and breast tissue derived cell lines. Dis Markers 2001;17:99-109. (Pubitemid 32964841)